Comment améliorer les stratégies thérapeutiques en radiothérapie des carcinomes in situ dans les sous groupes à bas risque ?

Text generated by AI based on an exclusive interview, revised and reviewed by

Yazid BELKACEMI
MD, PhD, Radiotherapist, Creteil, France

Overview in High Risk Patient Screening
Dana Haddad

MD, PhD, American Board Certified consultant breast radiologist

and Head of Breast Imaging at Healthbay Polyclinic in Dubai, UAE
How AI will help us to better define patient populations? What for?
Joseph GLIGOROV
oncologist, Paris, France
A titre personnel que vous apporte un congrès pluridisciplinaire ?
Patrice TAROUEL

Radiologue, Montpellier, France – Co-Président du BCU
What are the limitation of mammography?
Dana HADDAD
radiologist, UAE
Imaging value in liver metastatic detection?

Youssef EL FAKIR
Radiologist, Rabat , Maroco

Overview in High Risk Patient Screening